Results 151 to 160 of about 205,027 (361)
Progression and topographic subtypes of Terrien marginal degeneration
Acta Ophthalmologica, EarlyView.Abstract Purpose To report long‐term outcomes and to search for immunological and genetic risk factors in Terrien marginal degeneration (TMD). Methods Retrospective, in part prospective, hospital‐based longitudinal follow‐up study of 32 eyes of 16 Finnish patients from 2012 to 2023. Median follow‐up was 7.3 years (range, 0.3–15.2).
Minna Ruutila +8 more
wiley +1 more source
Radiation therapy for neovascular age-related macular degeneration
Clinical Ophthalmology, 2011 Robert Petrarca, Timothy L JacksonDepartment of Ophthalmology, King’s College Hospital NHS Foundation Trust, London, UKAbstract: Antivascular endothelial growth factor (anti-VEGF) therapies represent the standard of care for most patients ...
Robert Petrarca, Timothy L Jackson
doaj
Macular function impairment in eyes with early age-related macular degeneration [PDF]
, 1997 C Degli +4 more
openalex +1 more source
Acta Ophthalmologica, EarlyView.Abstract Purpose To evaluate test–retest variability (TRV) of the full‐field stimulus test (FST) in patients with retinitis pigmentosa (RP) and poor best‐corrected visual acuity (BCVA; ≤20/50 Snellen; ≥0.40 logMAR), and to assess the reliability of FST as a clinical endpoint in future RP trials.
J. S. Karuntu +2 more
wiley +1 more source
مجله دانشگاه علوم پزشکی گرگان, 2009 Background and Objective: Several studies have reported high prevalence of severe lack of cobalamine and Folate in aged people. The most important causes are: malnutrition, atrophic gastritis and drug use.
Javad Heravian (PhD) +5 more
doaj
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin [PDF]
, 1999 Neil M. Bressler
openalex +1 more source
Acta Ophthalmologica, EarlyView.Abstract Background Intravitreal Anti‐Vascular Endothelial Growth Factor (VEGF) rescues retinal vasculatures and prevents disease progression in patients with neovascular Age‐Related Macular Degeneration (nAMD). However, systemic anti‐VEGF may increase the risk of thromboembolic related complications including stroke and TIA. This study aims to explore
A. H. Falemban +5 more
wiley +1 more source
Low‐contrast visual acuity versus low‐luminance visual acuity in choroideremia
Clinical and Experimental Optometry, EarlyView., 2020 Clinical relevance Choroideremia is a progressive X‐linked inherited rod‐cone dystrophy. Patients present with nyctalopia and progressive visual field loss, but visual acuity remains well preserved early on. This study showed that low‐luminance visual acuity may be a useful clinical outcome measure during earlier disease stages.
Laura J Wood +6 more
wiley +1 more source
Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration [PDF]
, 1997 Ma'an Nasir +2 more
openalex +1 more source
Continuity of care and risk of vision loss in patients with newly developed macular degeneration
Acta Ophthalmologica, EarlyView.Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho +5 more
wiley +1 more source